Syndax Pharmaceuticals
SNDX
SNDX
72 hedge funds and large institutions have $128M invested in Syndax Pharmaceuticals in 2019 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 26 increasing their positions, 14 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.21% less ownership
Funds ownership: 63.37% → 63.16% (-0.21%)
20% less capital invested
Capital invested by funds: $160M → $128M (-$31.8M)
Holders
72
Holding in Top 10
1
Calls
$3.39M
Puts
$3.02M
Top Buyers
| 1 | +$2.99M | |
| 2 | +$680K | |
| 3 | +$486K | |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$415K |
| 5 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
+$375K |
Top Sellers
| 1 | -$3.32M | |
| 2 | -$1.68M | |
| 3 | -$1.34M | |
| 4 |
USAA
United Services Automobile Association
San Antonio,
Texas
|
-$1.15M |
| 5 |
CCIA
Campbell & Co Investment Adviser
Baltimore,
Maryland
|
-$367K |